---
title: Protheragen vs QPS
slug_a: obesityscientific
slug_b: qps
site: cro
review_signal_gate: closed
canonical_path: /compare/obesityscientific/qps
generated_by: BioBM Editorial AI
---

# Protheragen vs QPS

This comparison is auto-generated by BioBM Editorial AI and intended as an evidence-oriented side-by-side reference.

## Company A

Protheragen (obesityscientific) is listed for cro. Specialized preclinical CRO focused on obesity research, offering comprehensive animal models, pharmacokinetic/pharmacodynamic studies, bioanalysis, and safety assessment for anti-obesity drug development.

Services: 16. Modalities: 5. Indications: 1. Locations: 0. Certifications: 0. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (16).

Review summary: Review summary withheld until site-level review gate opens.

## Company B

QPS (qps) is listed for cro. QPS provides integrated contract research and clinical services spanning bioanalysis, preclinical development, and early-to-late phase clinical trials across multiple therapeutic areas including oncology, dermatology, and women's health.

Services: 23. Modalities: 5. Indications: 6. Locations: 9. Certifications: 1. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (23).

Review summary: Review summary withheld until site-level review gate opens.